Improving Lung Cancer Screening Uptake with Tailored Patient Navigation in Tribal Communities of Western Washington
Led by Fred Hutchinson Cancer Center · Updated on 2026-10-27
237
Participants Needed
2
Research Sites
4 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating whether tailored patient navigation PN can improve lung cancer screening LCS rates among American Indian and Alaska Native people in tribal communities in western Washington state. Lung cancer is a leading cause of death in this population, who also have high smoking rates. The study aims to address barriers that reduce LCS uptake by providing PN services designed specifically for these communities.
Participants are randomly assigned to one of two groups. One group receives tailored PN support and educational materials about LCS for 21 months. The other group receives enhanced usual care, including educational materials and a warm hand-off to their primary care provider for 6 months, followed by tailored PN support for 15 months. The study involves behavioral interventions, educational handouts, surveys, interviews, and review of health records.
Throughout the study, participants complete assessments such as low-dose chest CT scans to measure screening uptake over periods up to 21 months. Researchers also evaluate participants knowledge about LCS, quality of life, tobacco cessation rates, and engagement with navigation services. The trial lasts up to 21 months, with ongoing monitoring of screening completion and follow-up diagnostic steps.
CONDITIONS
Brief Title
Tailored Patient Navigation to Improve the Uptake of Lung Cancer Screening in Tribal Communities in Western Washington State, SACRED LUNGS Trial
Research Team
M
Matty Triplette, MD, MPH
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
National Institute on Minority Health and Health Disparities (NIMHD)
Collaborating Sponsor
How This Trial Compares With Other Options
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
Factors
Tailored Patient Navigation
Enhanced Usual Care
What it is
A personalized patient navigation program that includes one-on-one support, education, motivational interviewing, help addressing barriers, and scheduling assistance to improve lung cancer screening uptake among high-risk adults in tribal communities.
Enhanced usual care consists of standard educational materials about lung cancer screening, usual clinic care, and delayed access to tailored patient navigation if not screened within 6 months.
Role in the trial
Investigational arm: designed to actively increase participation in lung cancer screening using tailored navigation support.
Comparator arm: represents enhanced education and usual clinical pathways for lung cancer screening, with an option for delayed navigation.
Primary use
To increase the rate of lung cancer screening (low-dose CT scans) among high-risk adults by guiding participants through the screening process and reducing barriers.
To reflect enhanced current clinical practices for lung cancer screening, offering education and routine care with delayed navigation as a possible later aid.
How it is given or performed
Patient navigators provide individualized sessions by phone, video, and/or in-person, offering navigation, education, addressing cultural needs, supporting shared decision-making, and scheduling screening appointments as needed.
Participants receive educational materials outlining lung cancer screening, attend routine health care visits, and may access navigation if not screened after 6 months.
Evidence status
The effectiveness of tailored navigation to enhance lung cancer screening rates and reduce barriers in tribal communities is actively being studied. Results are not yet established.
Low-dose CT screening increases early detection and reduces lung cancer mortality in high-risk adults; education and navigation may further improve screening uptake in underserved populations.
Important limitations
Effectiveness is not yet proven for increasing screening rates or improving outcomes in this population. Implementation outside research settings, sustainability, and generalizability may be limited by context or resources.
Usual care, even when enhanced with education, often leads to underuse of screening among eligible high-risk individuals, especially in underserved and minority communities.
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
Who Can Participate
Age: 18Years +
All Genders
Healthy Volunteers
Eligibility Criteria
You may qualify if you...
Age between 50 and 77 years
Self-reported smoking history of at least 20 pack-years
Current or recent commercial tobacco use within the past 15 years
Seen by a primary care provider at a participating clinic within the past three years or willingness to establish care
Affiliation or participation in clinical staff or patient surveys and interviews as applicable
Adults aged 18 or older for clinical staff surveys and interviews
You will not qualify if you...
Chest CT scan performed within the past year
Personal history of lung cancer
Personal history of any cancer within the past 5 years, except basal cell or squamous cell skin cancer
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or virtual)
Intervention Period
Duration - Up to 21 months
Participants receive either tailored patient navigation support and educational materials for 21 months or enhanced usual care with educational materials and a warm hand-off to their primary care provider for 6 months followed by tailored navigation for 15 months.
Regular contacts as part of patient navigation activities
Follow-up and Assessment
Duration - Up to 21 months
Participants complete chest CT scans and other assessments to measure screening uptake and follow-up over the study period.
Periodic assessments and surveys throughout the study
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SCREENING
Number of Arms
2
Similar Trials
Restorative Justice-Based Lung Cancer Screening Support to Increase Screening Among Black Individuals in the RESTORE Trial
Using an Online Platform to Help Adults with Lung, Colorectal, Breast, or Prostate Cancer Track Medication Safety at Home
Phase II Study of SKB518 Alone or With Tislelizumab and Carboplatin in Adults With Lung Cancer
Educational Program to Improve Lung Cancer Screening Knowledge Among American Indian and Alaskan Native Smokers Using the Lung Toolkit
Phase II Study of Canakinumab to Prevent Lung Cancer in Patients with High-Risk Pulmonary Nodules
Evaluating CPAP Versus Deep Inspiration Breath Hold to Reduce Tumor Movement
During Stereotactic Body Radiation Therapy for Lung Cancer
Collecting Data on Side Effects and Tissue Responses in Adults Receiving Proton Therapy for Cancer
Educating Smokers Through Tobacco Quitlines to Increase Lung Cancer Screening Awareness
Support Program for Veterans with Lung Cancer to Improve Quality of Life and Care
Improving Health Outcomes by Early COPD Diagnosis and Treatment in Patients Being Evaluated for Lung Cancer
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Strengthening awareness and community resources for early detection of lung cancer through navigation guided screening in American Indian/Alaska Native clinics (SACRED LUNGS): Study protocol.